Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening

March 19, 2024 updated by: LaToya Green, University of Tennessee
The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.

Study Overview

Detailed Description

The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein. Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response. Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Tennessee
      • Memphis, Tennessee, United States, 38163
        • University of Tennessee Health Science Center
        • Contact:
        • Contact:
        • Principal Investigator:
          • LaToya L Green, EdD
        • Sub-Investigator:
          • Myra M Meekins, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy individuals between the age of 18 and 30

Exclusion Criteria:

  • Individuals with uncontrolled high blood pressure
  • Individuals with sickle cell anemia, current pregnancy
  • Individuals with a history of deep vein thrombosis
  • Individuals with diabetes
  • Individuals with active infection
  • Individuals with less than normal range of motion or muscle strength
  • Individuals with moderate to severe upper extremity injury in the past 12 months
  • Individuals with a current diagnosis of cancer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Myofascial Release
The Experimental group will receive a myofascial release pectoralis minor release intervention.
Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
Sham MFR.
Sham Comparator: Sham Myofascial Release
The Control group will receive a sham myofascial release pectoralis minor release intervention.
Myofascial release (MFR) is a technique that involves applying gentle sustained pressure into the myofascial connective tissue restrictions to eliminate pain and restore motion.
Blood flow restricted (BFR) exercise is the brief and non-continuous blockage of venous blood flow using a device that restricts the flow of blood while exercising. This technique is used to produce hypertrophy (muscle growth) and strength responses while exercising at a lighter load than traditionally required to produce a similar response.
Sham MFR.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scapular retraction strength
Time Frame: 8 weeks
Assess scapular retraction strength with a dynamometer
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
One repetition maximum (1RM)
Time Frame: 8 weeks
maximum amount of weight that can be lifted one time for scapular retractors on a row machine
8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length for the pectoralis minor
Time Frame: 8 weeks
Assess length of the pectoralis minor with a tape measure
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2023

Primary Completion (Estimated)

September 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

January 12, 2023

First Submitted That Met QC Criteria

January 24, 2023

First Posted (Actual)

February 2, 2023

Study Record Updates

Last Update Posted (Actual)

March 20, 2024

Last Update Submitted That Met QC Criteria

March 19, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 22-08926-XP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Muscle Strength

Clinical Trials on myofascial release

3
Subscribe